Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07357428 · ClinicalTrials.gov registry record · NA
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
A NA study of Stroke and Amyotrophic Lateral Sclerosis, sponsored by Paradromics.
- Recruiting
- Registry status
- NA
- Development phase
- 2
- Enrollment target
- 1
- Study location
NCT07357428: Recruiting NA study of Stroke and Amyotrophic Lateral Sclerosis, sponsored by Paradromics.
NCT07357428 is a NA study of Stroke and Amyotrophic Lateral Sclerosis that is actively recruiting participants, run by Paradromics. The registered enrollment target is 2 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07357428, a NA study of Stroke and Amyotrophic Lateral Sclerosis, is actively recruiting participants, sponsored by Paradromics.
- RECRUITING
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
- 1
- Study location
Study Summary
The Connect-One Study is an early feasibility study to obtain preliminary device safety information for the Connexus Brain-Computer Interface (BCI). The Connexus BCI is intended to be used as: (1) an assistive communication device to decode imagined language correlates and speech for patients with impaired communication as a result of severe loss of voluntary motor control; and (2) to provide control of computer devices for individuals with severe loss of voluntary motor control of the upper extremity.
Primary Outcome
Device Related Adverse Events: Number of subjects with device-related adverse events
Conditions Studied
Interventions
- DEVICE Connexus Brain-Computer Interface
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2026-01 |
| Est. Completion | 2032-01 |
| Phase | NA |
What NCT07357428 shows while recruiting
NCT07357428 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 6 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Connexus Brain-Computer Interface is the first listed.
NCT07357428 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT07357428 about?
NCT07357428 is a clinical study titled "Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)". The Connect-One Study is an early feasibility study to obtain preliminary device safety information for the Connexus Brain-Computer Interface (BCI). The Connexus BCI is intended to be used as: (1) an assistive communication device to decode imagined language correlates and speech for patients with i...
What is the current status of trial NCT07357428?
This trial is currently recruiting. It is a NA study. The enrollment target is 2 participants. The study started on 2026-01. Estimated completion is 2032-01.
What conditions does trial NCT07357428 study?
This clinical trial studies the following conditions: Stroke, Amyotrophic Lateral Sclerosis, Cervical Spinal Cord Injury, Tetraplegia/Tetraparesis, Dysarthria.
What interventions are being tested in trial NCT07357428?
The interventions under investigation include: Connexus Brain-Computer Interface (DEVICE).
Who is sponsoring clinical trial NCT07357428?
This trial is sponsored by Paradromics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07357428 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07357428's enrollment target sits among peer trials
2 454th of 454 the lowest of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia